SAFETY OF TEPOTINIB Plus OSIMERTINIB IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) AMPLIFICATION FOLLOWING FIRST-LINE OSIMERTINIB: INSIGHT 2 PRIMARY ANALYSIS
ONCOLOGY NURSING FORUM（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要